RFP | February 17, 2014
U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases announces the availability of funding for implementation of the Innovative Technologies and Assays in Support of HIV Cure Research (R41/R42) Small Business Innovation Research (SBIR) Grant. The purpose of this grant is to develop sensitive and quantitative assays, methods, or imaging techniques, including the development or novel applications of imaging agents or probes that can be applied to the measurement of residual HIV reservoirs in HIV-positive individuals, who are on effective antiretroviral therapy. Contractors should refer to Section VII . . .